Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Ty Kiser to Anti-Bacterial Agents

This is a "connection" page, showing publications Ty Kiser has written about Anti-Bacterial Agents.

 
Connection Strength
 
 
 
2.633
 
  1. Molina KC, Miller MA, Mueller SW, Van Matre ET, Krsak M, Kiser TH. Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin. Clin Pharmacokinet. 2022 03; 61(3):363-374.
    View in: PubMed
    Score: 0.414
  2. Van Matre ET, Teitelbaum I, Kiser TH. Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients. Antimicrob Agents Chemother. 2020 04 21; 64(5).
    View in: PubMed
    Score: 0.369
  3. Kiser TH, Reynolds PM, Moss M, Burnham EL, Ho PM, Vandivier RW. Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study. Pharmacotherapy. 2019 03; 39(3):242-252.
    View in: PubMed
    Score: 0.341
  4. Reilly AM, Ding MX, Rower JE, Kiser TH. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations. J Clin Pharmacol. 2019 07; 59(7):997-1005.
    View in: PubMed
    Score: 0.340
  5. Hong LT, Goolsby TA, Sherman DS, Mueller SW, Reynolds P, Cava L, Neumann R, Kiser TH. Continuous infusion vs intermittent vancomycin in neurosurgical intensive care unit patients. J Crit Care. 2015 Oct; 30(5):1153.e1-6.
    View in: PubMed
    Score: 0.264
  6. Fish DN, Kiser TH. Correlation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia. Pharmacotherapy. 2013 Oct; 33(10):1022-34.
    View in: PubMed
    Score: 0.229
  7. Kiser TH, Hoody DW, Obritsch MD, Wegzyn CO, Bauling PC, Fish DN. Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Antimicrob Agents Chemother. 2006 Jun; 50(6):1937-45.
    View in: PubMed
    Score: 0.141
  8. Tegethoff JI, Teitelbaum I, Kiser TH. Rapid and Effective Treatment of Peritonitis in Peritoneal Dialysis Patients with Intravenous Dalbavancin. Am J Case Rep. 2024 Jan 26; 25:e942755.
    View in: PubMed
    Score: 0.120
  9. Johnson TM, Molina KC, Miller MA, Kiser TH, Huang M, Mueller SW. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. Int J Antimicrob Agents. 2021 Apr; 57(4):106310.
    View in: PubMed
    Score: 0.098
  10. Kassel LE, Van Matre ET, Foster CJ, Fish DN, Mueller SW, Sherman DS, Wempe MF, MacLaren R, Neumann RT, Kiser TH. A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8-Hour and 12-Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients. Pharmacotherapy. 2018 09; 38(9):921-934.
    View in: PubMed
    Score: 0.082
  11. Kiser TH, Vandivier RW. Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter? Curr Opin Pulm Med. 2015 Mar; 21(2):142-8.
    View in: PubMed
    Score: 0.065
  12. Hafermann MJ, Kiser TH, Lyda C, Fish DN, Barber GR, Wempe MF, Cleveland JC. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery. J Thorac Cardiovasc Surg. 2014 Jun; 147(6):1925-30.
    View in: PubMed
    Score: 0.060
  13. Mueller SW, Kiser TH, Anderson TA, Neumann RT. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium. Ann Pharmacother. 2012 Dec; 46(12):e35.
    View in: PubMed
    Score: 0.055
  14. Kalmanson OA, McLoughlin KC, Kiser TH, Gubbels SP. Debilitating Gentamicin Ototoxicity: Case Report and Recommendations Against Routine Use in Surgical Prophylaxis. Ann Otol Rhinol Laryngol. 2023 Dec; 132(12):1686-1689.
    View in: PubMed
    Score: 0.029
  15. Farrar JE, Mueller SW, Stevens V, Kiser TH, Taleb S, Reynolds PM. Correlation of antimicrobial fraction unbound and sieving coefficient in critically ill patients on continuous renal replacement therapy: a systematic review. J Antimicrob Chemother. 2022 02 02; 77(2):310-319.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)